Why the study?
Does ablation and pacing therapy improve clinical outcomes and mortality in patients with medically refractory atrial fibrillation compared to medical therapy?
Does ablation and pacing therapy improve clinical outcomes and mortality in patients with medically refractory atrial fibrillation compared to medical therapy?
Ablation and pacing therapy is an effective strategy with low 1-year mortality comparable to medical therapy for patients with medically refractory atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports ablation-pacing in refractory AF; reinforces Level 1 evidence for improved outcomes with comparable mortality.
Ablation and pacing therapy improves a broad range of clinical outcomes for patients with medically refractory atrial fibrillation. The calculated 1-year mortality rates after this therapy are low and comparable with medical therapy.
No takes yet. Share an insight, caveat, or question.
Wood et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: